# Pulmonary Hypertension and Anastrozole Trial

> **NCT03229499** · PHASE2 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 84 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Anastrozole
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03229499
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-07
- **Primary completion:** 2022-07-22
- **Final completion:** 2022-07-22
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2024-05-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03229499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03229499, "Pulmonary Hypertension and Anastrozole Trial". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03229499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*